HARVARD BIOSCIENCE, INC. (HBIO) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 24.79M USD | Liabilities, Current |
| Cash and equivalents | 6.50M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 14.50M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 22.23M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $24.79M | $6.50M | (m) | $14.50M | $22.23M | (m) |
| 2026-03-31 | (m) | $23.86M | $7.10M | (m) | $14.57M | $22.20M | (m) |
| 2025-12-31 | (m) | $21.96M | $8.61M | (m) | $16.04M | $20.80M | (m) |
| 2025-09-30 | (m) | $54.40M | $6.82M | (m) | $12.11M | $21.60M | (m) |
| 2025-06-30 | (m) | $55.20M | $7.44M | (m) | $11.94M | $22.25M | (m) |
| 2025-03-31 | (m) | $55.60M | $5.55M | (m) | $13.48M | $22.82M | (m) |
| 2024-12-31 | (m) | $54.96M | $4.11M | (m) | $14.87M | $23.25M | (m) |
| 2024-09-30 | (m) | $22.75M | $4.57M | (m) | $12.83M | $25.99M | (m) |
| 2024-06-30 | (m) | $22.62M | $4.05M | (m) | $12.49M | $25.13M | (m) |
| 2024-03-31 | (m) | $25.68M | $4.25M | (m) | $15.31M | $24.14M | (m) |
| 2023-12-31 | (m) | $26.54M | $4.28M | (m) | $16.10M | $24.72M | (m) |
| 2023-09-30 | (m) | $24.20M | $5.34M | (m) | $14.98M | $25.82M | (m) |
| 2023-06-30 | (m) | $22.94M | $4.32M | (m) | $16.90M | $26.09M | (m) |
| 2023-03-31 | (m) | $23.22M | $3.79M | (m) | $17.74M | $26.86M | (m) |
| 2022-12-31 | (m) | $23.25M | $4.51M | (m) | $16.70M | $26.44M | (m) |
| 2022-09-30 | (m) | $21.36M | $5.14M | (m) | $15.02M | $26.12M | (m) |
| 2022-06-30 | (m) | $23.35M | $4.26M | (m) | $17.85M | $29.34M | (m) |
| 2022-03-31 | (m) | $27.23M | $5.43M | (m) | $20.27M | $28.71M | (m) |
| 2021-12-31 | (m) | $25.32M | $7.82M | (m) | $21.83M | $27.59M | (m) |
| 2021-09-30 | (m) | $23.51M | $5.55M | (m) | $18.34M | $25.98M | (m) |
| 2021-06-30 | (m) | $23.27M | $6.24M | (m) | $17.39M | $24.71M | (m) |
| 2021-03-31 | (m) | $20.72M | $5.82M | (m) | $17.07M | $22.68M | (m) |
| 2020-12-31 | (m) | $21.05M | $8.32M | (m) | $17.77M | $22.26M | (m) |
| 2020-09-30 | (m) | $21.25M | $2.81M | (m) | $13.88M | $22.69M | (m) |
| 2020-06-30 | (m) | $22.66M | $2.63M | (m) | $14.71M | $23.18M | (m) |
| 2020-03-31 | (m) | $23.48M | $5.88M | (m) | $15.43M | $23.14M | (m) |
| 2019-12-31 | (m) | $25.31M | $8.34M | (m) | $20.70M | $22.06M | (m) |
| 2019-09-30 | (m) | $21.70M | $6.84M | (m) | $17.09M | $23.89M | (m) |
| 2019-06-30 | (m) | $20.86M | $4.93M | (m) | $18.39M | $25.29M | (m) |
| 2019-03-31 | (m) | $24.14M | $5.03M | (m) | $18.79M | $26.56M | (m) |
| 2018-12-31 | (m) | $21.51M | $8.17M | (m) | $21.46M | $25.09M | (m) |
| 2018-09-30 | (m) | $19.26M | $6.66M | (m) | $17.88M | $25.74M | (m) |
| 2018-06-30 | (m) | $22.19M | $5.62M | (m) | $19.59M | $25.64M | (m) |
| 2018-03-31 | (m) | $22.28M | $5.99M | (m) | $18.96M | $27.90M | (m) |
| 2017-12-31 | (m) | $14.04M | $5.73M | (m) | $16.24M | $21.35M | (m) |
| 2017-09-30 | (m) | $13.95M | $5.84M | (m) | $15.27M | $21.38M | (m) |
| 2017-06-30 | (m) | $13.24M | $4.72M | (m) | $15.98M | $20.37M | (m) |
| 2017-03-31 | (m) | $14.06M | $4.60M | (m) | $15.48M | $20.28M | (m) |
| 2016-12-31 | (m) | $14.60M | $5.60M | (m) | $15.75M | $19.95M | (m) |
| 2016-09-30 | (m) | $14.44M | $5.34M | (m) | $15.12M | $21.23M | (m) |
| 2016-06-30 | (m) | $14.85M | $3.63M | (m) | $16.35M | $22.21M | (m) |
| 2016-03-31 | (m) | $15.90M | $4.17M | (m) | $18.02M | $22.22M | (m) |
| 2015-12-31 | (m) | $19.41M | $6.74M | (m) | $17.55M | $22.34M | (m) |
| 2015-09-30 | (m) | $17.27M | $6.09M | (m) | $15.59M | $23.01M | (m) |
| 2015-06-30 | (m) | $21.23M | $7.40M | (m) | $18.54M | $23.07M | (m) |
| 2015-03-31 | (m) | $19.76M | $8.03M | (m) | $16.02M | $22.09M | (m) |
| 2014-12-31 | (m) | $18.10M | $14.13M | (m) | $16.14M | $20.53M | (m) |
| 2014-09-30 | (m) | $15.63M | $26.73M | (m) | $14.28M | $18.06M | (m) |
| 2014-06-30 | (m) | $16.36M | $26.43M | (m) | $14.31M | $17.21M | (m) |
| 2014-03-31 | (m) | $15.48M | $25.84M | (m) | $14.32M | $15.77M | (m) |
| 2013-12-31 | (m) | $16.09M | $25.77M | (m) | $13.88M | $15.78M | (m) |
| 2013-09-30 | (m) | $13.49M | $36.93M | (m) | $13.36M | $18.03M | (m) |
| 2013-06-30 | (m) | $13.30M | $34.10M | (m) | $13.83M | $18.26M | (m) |
| 2013-03-31 | (m) | $13.12M | $23.75M | (m) | $14.19M | $17.73M | (m) |
| 2012-12-31 | (m) | $9.90M | $20.68M | (m) | $14.36M | $17.76M | (m) |
| 2012-09-30 | (m) | $9.53M | $20.29M | (m) | $13.60M | $17.99M | (m) |
| 2012-06-30 | (m) | $9.91M | $18.66M | (m) | $15.07M | $17.75M | (m) |
| 2012-03-31 | (m) | $10.73M | $17.24M | (m) | $16.17M | $18.38M | (m) |
| 2011-12-31 | (m) | $9.56M | $17.92M | (m) | $15.08M | $18.16M | (m) |
| 2011-09-30 | (m) | $10.21M | $16.24M | (m) | $13.62M | $20.10M | (m) |
| 2011-06-30 | (m) | $10.34M | $21.75M | (m) | $14.46M | $19.00M | (m) |
| 2011-03-31 | (m) | (m) | $20.09M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $11.30M | $19.70M | (m) | $15.44M | $15.83M | (m) |
| 2010-09-30 | (m) | (m) | $17.22M | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $15.72M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $16.59M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $13.70M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |